- Home
- TLRY vs PX Comparison
TLRY vs PX Comparison
Compare TLRY & PX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLRY
- PX
- Stock Information
- Founded
- TLRY N/A
- PX 1992
- Country
- TLRY Canada
- PX United States
- Employees
- TLRY N/A
- PX N/A
- Industry
- TLRY Medicinal Chemicals and Botanical Products
- PX Investment Managers
- Sector
- TLRY Health Care
- PX Finance
- Exchange
- TLRY Nasdaq
- PX Nasdaq
- Market Cap
- TLRY 1.5B
- PX 1.2B
- IPO Year
- TLRY 2018
- PX 2021
- Fundamental
- Price
- TLRY $1.35
- PX $12.04
- Analyst Decision
- TLRY Hold
- PX Hold
- Analyst Count
- TLRY 3
- PX 9
- Target Price
- TLRY $1.88
- PX $12.67
- AVG Volume (30 Days)
- TLRY 30.1M
- PX 479.6K
- Earning Date
- TLRY 01-07-2025
- PX 11-07-2024
- Dividend Yield
- TLRY N/A
- PX 1.16%
- EPS Growth
- TLRY N/A
- PX N/A
- EPS
- TLRY N/A
- PX 0.10
- Revenue
- TLRY $812,037,000.00
- PX $274,501,000.00
- Revenue This Year
- TLRY $18.31
- PX $17.95
- Revenue Next Year
- TLRY $5.26
- PX $5.72
- P/E Ratio
- TLRY N/A
- PX $119.13
- Revenue Growth
- TLRY 24.76
- PX 15.82
- 52 Week Low
- TLRY $1.33
- PX $7.08
- 52 Week High
- TLRY $2.97
- PX $12.38
- Technical
- Relative Strength Index (RSI)
- TLRY 32.83
- PX 64.69
- Support Level
- TLRY $1.36
- PX $11.78
- Resistance Level
- TLRY $1.51
- PX $12.38
- Average True Range (ATR)
- TLRY 0.09
- PX 0.37
- MACD
- TLRY -0.03
- PX 0.06
- Stochastic Oscillator
- TLRY 4.08
- PX 79.03
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
About PX P10 Inc.
P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.